alexa
Reach Us +441474556909
Jerry S. Wolinsky | OMICS International
ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Jerry S. Wolinsky

Jerry S. Wolinsky Department of Neurology, University of Texas Health Science Center-Houston, Houston, TX, USA

Biography

Jerry S. Wolinsky, M.D., is the interim chair of Neurology.  He is also the Bartels Family Professor of Neurology and a member of the graduate faculty of the Graduate School of Biomedical Sciences at The University of Texas Health Science Center at Houston.

 At the Medical School, he directs the Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center. Dr. Wolinsky received his M.D. degree from The University of Illinois in 1969. Residency training in clinical neurology, a fellowship in experimental neuropathology and faculty appointment at The University of California San Francisco followed. While in San Francisco his research interests concentrated on the pathogenesis of viral infections of the nervous system, and his clinical efforts began to focus on experimental therapeutics of infections of the central nervous system and multiple sclerosis. He subsequently joined the faculty of The Johns Hopkins University Schools of Medicine, and Hygiene and Public Health in 1978 before settling in Houston in 1983. In Baltimore he applied more molecular tools to his basic investigations and became more interested in the primary and secondary immunopathogenesis of neural disease.

 He is currently active in the design, implementation, conduct and analysis of clinical trials of multiple sclerosis and conducts basic and applied research in quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in demyelinating diseases. He has served on review and advisory committees of the National Institutes of Health, the National Multiple Sclerosis Society, the Multiple Sclerosis International Federation, the Food and Drug Administration, numerous pharmaceutical houses, and the Sylvia Lawry Centre for Multiple Sclerosis Research. He was an Associate Editor of ACP Scientific American Medicine and is on the editorial board of Multiple Sclerosis Journal and Multiple Sclerosis and Related Diseases.

 He is recognized in The Best Doctors in America and America’s Top Doctors. He has authored over 300 publications dealing with issues of relevance to neurovirology and neuroimmunology, clinical trials and the imaging of multiple sclerosis.

 

Research Interest

 Clinical Interests: Multiple Sclerosis and Demyelinating Diseases of the CNS Quantitative Magnetic Resonance Imaging Clinical Trial Design

Research Interest: Sanofi-Aventis: MRI Analysis Center for the teriflunomide studies in multiple sclerosis National Institutes of Health: Combination Therapy in Multiple Sclerosis

 

Publications

Global Speakers in the subject

Global Experts in the subject

Top